William Honnen

2.7k total citations
41 papers, 2.1k citations indexed

About

William Honnen is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, William Honnen has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 20 papers in Infectious Diseases and 20 papers in Immunology. Recurrent topics in William Honnen's work include HIV Research and Treatment (22 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Immune Cell Function and Interaction (12 papers). William Honnen is often cited by papers focused on HIV Research and Treatment (22 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Immune Cell Function and Interaction (12 papers). William Honnen collaborates with scholars based in United States, Japan and Canada. William Honnen's co-authors include Abraham Pinter, Miroslaw K. Górny, Susan Zolla‐Pazner, Samuel C. Kayman, S A Tilley, Chavdar Krachmarov, Yuxian He, Habib Zaghouani, M W Hilgartner and Kathy Revesz and has published in prestigious journals such as Nature Communications, Nature Immunology and The Journal of Immunology.

In The Last Decade

William Honnen

40 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Honnen United States 25 1.5k 907 857 583 535 41 2.1k
Miroslawa Bilska United States 15 1.9k 1.3× 810 0.9× 1.0k 1.2× 298 0.5× 465 0.9× 19 2.1k
Carol D. Weiss United States 27 1.6k 1.1× 1.2k 1.4× 756 0.9× 398 0.7× 669 1.3× 65 2.6k
Sanjay Phogat United States 24 1.6k 1.1× 668 0.7× 1.2k 1.4× 688 1.2× 751 1.4× 41 2.3k
Timothy Fouts United States 27 1.3k 0.9× 690 0.8× 1.0k 1.2× 408 0.7× 530 1.0× 53 2.1k
Laura M. Walker United States 22 1.2k 0.8× 1.0k 1.2× 967 1.1× 667 1.1× 726 1.4× 41 2.5k
Maria G. Salazar United States 10 2.4k 1.6× 1.2k 1.4× 1.1k 1.3× 360 0.6× 673 1.3× 14 2.8k
Huxiong Hui United States 9 2.4k 1.6× 1.3k 1.4× 959 1.1× 343 0.6× 635 1.2× 9 2.8k
Nicole A. Doria‐Rose United States 29 2.3k 1.6× 924 1.0× 1.5k 1.7× 818 1.4× 946 1.8× 68 3.0k
Phillipe N. Nyambi United States 29 1.9k 1.3× 1.2k 1.3× 808 0.9× 371 0.6× 401 0.7× 78 2.3k
Franz Steindl Austria 19 2.4k 1.6× 862 1.0× 1.5k 1.8× 1.1k 1.9× 993 1.9× 41 3.1k

Countries citing papers authored by William Honnen

Since Specialization
Citations

This map shows the geographic impact of William Honnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Honnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Honnen more than expected).

Fields of papers citing papers by William Honnen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Honnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Honnen. The network helps show where William Honnen may publish in the future.

Co-authorship network of co-authors of William Honnen

This figure shows the co-authorship network connecting the top 25 collaborators of William Honnen. A scholar is included among the top collaborators of William Honnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Honnen. William Honnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrara, Fortunato, Sara D’Angelo, Laura Spector, et al.. (2023). Insights into next generation sequencing guided antibody selection strategies. Scientific Reports. 13(1). 18370–18370. 12 indexed citations
2.
Ferrara, Fortunato, Sara D’Angelo, André A. Teixeira, et al.. (2022). A pandemic-enabled comparison of discovery platforms demonstrates a naive antibody library can match the best immune-sourced antibodies. Nature Communications. 13(1). 462–462. 24 indexed citations
3.
Irvine, Edward B., Patricia A. Darrah, Sally Shin, et al.. (2021). Robust IgM responses following intravenous vaccination with Bacille Calmette–Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques. Nature Immunology. 22(12). 1515–1523. 68 indexed citations
4.
Choudhary, Alok, Deendayal Patel, William Honnen, et al.. (2018). Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid of Mycobacterium tuberculosis, and Complexity of Antibody Specificities toward This Antigen. The Journal of Immunology. 200(9). 3053–3066. 50 indexed citations
7.
Lynch, Rebecca M., Rong Rong, Bing Li, et al.. (2010). Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection. Virology. 404(1). 59–70. 16 indexed citations
8.
Burioni, Roberto, Miroslaw K. Górny, Tetsuya Kimura, et al.. (2006). Session 6: Infectious disease. Human Antibodies. 15(1-2). 29–31. 1 indexed citations
9.
11.
He, Yuxian, William Honnen, Chavdar Krachmarov, et al.. (2002). Efficient Isolation of Novel Human Monoclonal Antibodies with Neutralizing Activity Against HIV-1 from Transgenic Mice Expressing Human Ig Loci. The Journal of Immunology. 169(1). 595–605. 47 indexed citations
12.
Krachmarov, Chavdar, et al.. (2001). V3-Specific Polyclonal Antibodies Affinity Purified from Sera of Infected Humans Effectively Neutralize Primary Isolates of Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 17(18). 1737–1748. 47 indexed citations
14.
Wu, Zhiwei, Samuel C. Kayman, William Honnen, et al.. (1995). Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain. Journal of Virology. 69(4). 2271–2278. 68 indexed citations
15.
Pinter, Abraham, William Honnen, Kathy Revesz, & Ruth Herz. (1992). Identification of Large Glycosylated Proteins Recognized by Monoclonal Antibodies Against HIV-1 gag Proteins. AIDS Research and Human Retroviruses. 8(8). 1341–1344. 3 indexed citations
16.
Tilley, S A, et al.. (1991). A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity. Research in Virology. 142(4). 247–259. 112 indexed citations
17.
Pinter, Abraham & William Honnen. (1989). Biochemical characterization of cell-associated and extracellular products of the friend spleen focus-forming virus env gene. Virology. 173(1). 136–143. 20 indexed citations
18.
Pinter, Abraham, William Honnen, S A Tilley, et al.. (1989). Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. Journal of Virology. 63(6). 2674–2679. 252 indexed citations
19.
Pinter, Abraham & William Honnen. (1988). A sensitive radioimmunoprecipitation assay for human immunodeficiency virus (HIV). Journal of Immunological Methods. 112(2). 235–241. 13 indexed citations
20.
Pinter, Abraham & William Honnen. (1983). Topography of murine leukemia virus envelope proteins: characterization of transmembrane components. Journal of Virology. 46(3). 1056–1060. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026